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Leprosy is an infectious condition that has a chronic
evolution caused by the Mycobacterium leprae. It very often
attacks the nasal cavities mucosa independent of its clinical
form, even before skin lesions or lesions to other parts of
the body arise, in the presence or not of clinical complaints.
Aim: To show the efficiency of nasal endoscopy to identify
endonasal mucosa lesions and the importance of the
Otorhinolaryngologist in the diagnosis and follow-up of
Leprosy patients. Study Design: Clinical history study.
Material and Method: a historic study was performed with
173 patient’s records without previous treatment from 1990
to 2000 at the Otorhinolaryngology Services, Instituto de
Pesquisas Clinicas Hospital Evandro Chagas, Fiocruz. Results:
All of the patients showed nasal lesions, 121 with and 52
without clinical complaints. Discussion: Nasal cavities
endoscopy exam enabled early identification of the mucosa
alteration in Leprosy patients as well as how to identify the
evolution of the lesions. This type of exam also helps to
establish local treatment. Conclusion: The evaluation and
follow-up of Leprosy patients by the Otorhinolaryngologist
in a multidisciplinary team are justified and offer the patient
early diagnosis and specific treatment.
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INTRODUCTION
The agent that causes Leprosy is a bacillus named
Mycobacterium leprae or Hansen bacillus, which belongs to
the family of Mycobacterium, which include many different
microorganisms that cause or not disease in humans. It is
alcohol acid-resistant, does not get discolored with alcohol
and acids and is stained by acid fucsin in red 1. It is an
obligatory intracellular parasite, presenting affinity with skin
cells and peripheral nerve cells. Hansen bacillus reproduces
slowly. Its average time of multiplication is 12 to 14 days,
very long if compared to tuberculosis bacillus, which takes
20 hours. This biological slowness of the bacillus explains its
chronic progression and the long period of incubation, which
occurs on average from 2 to 5 years. Humans are considered
the only natural reservoir for disease transmission; however,
some animals such as chimpanzees (Pan troglodytes),
mangabei monkey (Dercocebus torquatus atys) and
armadillo (Dasypus novencintus) could be probable
reservoirs of the infection, given that in these three species
leprosy is naturally acquired 2. According to Lombardi et al.
(1990)3, the social environment seems to be important in
the transmission of the disease, and there is no question
about the correlation between poverty and risk of leprosy,
with clear delimitation of the more susceptible group among
low-income populations, but not knowing whether this factor
is related with nutritional status, home agglomeration or
presence of other concomitant diseases, explaining the
endemics of the disease. Leprosy may affect both genders,
and it finds more cases in men, but there is no explanation
to this fact. The initial reason for the present paper was the
fact that there are few studies published in the literature
about the presence of lesions in paranasal sinuses mucosa,
observed through endoscopic study performed by
Otorhinolaryngologists. The use of optical fiber as a routine
may increase the level of success in locating and identifying
mucosa affections that occur in leprosy patients.
LITERATURE REVIEW
Chacko et al. (1979)4 described that Mycobacterium
leprae may be found in many different parts of the body
surface, such as skin of the extremities, earlobes, helix, anti-
helix, tragus, alar cartilage, septum and testicles. The
temperature in these areas is lower than the normal body
temperature, providing a favorable environment for the
bacillus. Multibacilli untreated patients are a source of
infection, whereas patients with paucibacillary and
undetermined forms, with negative bacilloscopy, in addition
to infected and asymptomatic people, may have an important
role in the transmission of the disease.
The transmission of the disease occurs by direct
contagious through prolonged contact between untreated
multibacilli patients and non-infected subjects, even though
there is the unconfirmed possibility that it is processed
through indirect methods, with contaminated objects and/
or vectors.3,5-7
We can also note the importance of nasal mucous in
the transmission of the infection, which may be a primordial
factor for the dissemination of the disease, but other paths
may be involved. The nasal mucosa is considered as entry
and exit doors for Mycobacterium leprae in many cases
considering how vulnerable the openings are and the free
access to the bacilli.3,7-9
It is admitted that inoculation can happen through
the nasal mucosa and by means of continuity solutions, such
as damaged nodules on the skin, breast milk, as well as cuts
and scratches on the skin of patients that may be transmissions
routes, with incubation period that varies from 2 to 5 years,
on average. Predisposed patients may have family contacts
with patients that have multibacillary forms, extra-home
contacts with multibacilli patients and contact with patients
that have the paucibacillary form.
There is no uniformity in relation to disease
distribution, but the areas of higher prevalence are in less
developed regions. An important fact concerning Leprosy is
that most endemic countries are located in tropical and
subtropical weather, where there are low social-economic
levels, people living in poor housing, nutritional and hygiene
conditions, with poor medical support and ineffective
preventive control of the disease; Brazil ranks second in
leprosy, behind India 10.
Leprosy is a public health problem in developing
countries and the magnitude of Hansen’s endemics is the
number of existing cases in a specific area and those that
are recorded annually, either the absolute number of cases
in a given moment or diagnosed in the year, or the relative
number, which is the coefficient of prevalence or records.
Brazil has an agreed goal with WHO to reduce the prevalence
rate to less than one case of Leprosy per 10,000 inhabitants
by 2005.3,6,7-11
The diagnosis is made by clinical history and
dermatological-neurological exam, complemented by tests
and laboratory exams, such as bacilloscopic examination,
performed in all patients with clinical suspicion of the
condition. The sites of material collection are areas that have
sensitivity affection or active lesions, such as smear of active
lesion or area with sensitivity abnormalities. In the absence
of lesions or numb areas, the collection is made through the
smear of four sites: two auricular lobes and two elbows, to
be stained with Ziehl-Neelsen solution.1,2,10
Many authors are unanimous about the presence of
bacillus in the nasal mucus, referring to the diagnostic value
of the exam, as well as to the prophylactic profile, associated
with clinical examination and investigation of bacilli in the
skin lesions. The mucus is positive in a high percentage of
patients with Lepromatous and Borderline leprosy, provided
that repeated exams are performed, given that they may
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sometimes be negative.
According to Cerruti et al. (1945)12, in the Neural form,
the mucus exam does not allow early diagnosis, given that
the positivity occurs after the evidence of other symptoms,
either dermatological or neurological, sufficient to lead to
the diagnosis.
The clinical presentations of leprosy comply with
the spectral classification by Ridley and Jopling, from the
60’s, in which we can find Tuberculoid form, polar stable
(TT), with negative bacilloscopy, major cell response,
limited lesions and few bacilli; LL form (polar Lepromatous
or Virchowian form), pole of high sensitivity to M. leprae,
with skin lesions that are diffusely distributed on the skin
and exacerbated humoral response, and the forms from
the Borderline group (unstable): BT (paucibacillary), BB
and BL (multibacillary). It is important to mention the pure
Neural form (few bacilli) and the Undetermined form (I),
responsible for the initial manifestation of the disease, in
which the host response is insufficiently differentiated to
enable classification, which may evolve to spontaneous
cure or polarization, depending on the capacity to form
cell immune response against M. leprae.
The chronic progression of Leprosy may be
manifested sometimes by acute phenomena, which are
named reaction episodes, related with the immune status
of the subject; they may be present both in the treatment
or after discharge and they do not require suspension or
restart of polychemotherapy. Reaction episodes are types
I, II and Neural. Type I reactions are mediated by cells
(cell immunity) and occur in paucibacillary patients. Type
II reactions are mediated by antibodies (humoral immunity)
2-10 and occur in forms LL and BL.
Treatment is mainly in outpatient settings and primary
health care centers use an association of drugs, standard
polychemotherapy OMS (PQT/OMS), using Rifampicin,
Dapsone and Clofazimine. Treatment course varies from six
months to one year. After two weeks from onset of treatment,
the Hansen patient is not longer infecting.2-10
As to nasal manifestations of the disease, Leloir
(1886)13 referred to the affection of nasal, mouth, throat,
larynx and eye mucosa, which could be invaded since the
beginning of skin tuberous eruption, especially of the nose.
As years went by, many publications unanimously
confirmed the nose as the initial site of Hansen’s
lesions.4,5,11-19
The nasal mucosa will be considered affected when
we evidence, by anterior and posterior rhinoscopy, typical
and individualized lesions of leprous rhinitis, such as
infiltration, lepromas, ulceration and perforation, as well as
other observed aspects that are not part of leprous rhinitis,
such as discoloration or paleness of the mucosa, congestion,
ectasias, vasculitis, crusts, atrophy, dryness and presence
of blood, which may be found in other nasal affections. In
many patients, however, these aspects were determined
by the leprous infections, as demonstrated by the
bacterioscopy, and especially at the histopathology,
evidencing the perivascular and neural infiltration specific
to Leprosy.5,12,20
The performance of ENT examination as a routine in
Hansen’s patients, using nasal speculum or rigid and flexible
endoscope, may provide further accuracy for the
identification of lesions that had not been visualized before,
enabling the diagnosis, in association with clinical history,
plus its use to follow up patients so as to prevent sequelae.
OBJECTIVES
Specific Objective
To confirm the efficacy of endoscopic examination
in the identification of mucosa lesions of paranasal sinuses
in patients with Leprosy, regardless of the clinical
presentation.
MATERIAL AND METHODS
After the approval of the project by the Technical
and Scientific Medical Ethical Committee (FIOCRUZ), we
performed a retrospective study in which we assessed the
medical charts of patients with Leprosy of the Service of
Otorhinolaryngology, FIOCRUZ, from 1990 to 2000, without
previous treatment and regardless of clinical presentation
or ENT complaints, and no differentiation between gender,
race, age or social class. The patients were seen in the
Ambulatory Souza Araújo, FIOCRUZ, responsible for the
diagnostic investigation, clinical progression and treatment.
They were classified according to number of bacilli
(multibacillary or paucibacillary) and clinical presentation
by clinical history, sensitivity tests, bacilloscopy and later
referred to the Service of Otorhinolaryngology and
Endoscopy, Instituto de Pesquisa Clínica Evandro Chagas
(IPEC), FIOCRUZ. In the service, the patients were
submitted to conventional ENT examination using halogen
light photophore, sterile nasal speculum for anterior
rhinoscopy, disposable wood spatula for oropharyngoscopy
and laryngeal mirrors number six for indirect laryngoscopy,
completing the endoscopic study of paranasal sinuses using
rigid 30o endoscope. There was no need to use topical
anesthesia but some patients required cleaning of nasal
cavities with sterile solution at 0.9% to remove crusts, so
as to facilitate the identification of lesions during the
endoscopic examination.
After the ENT examination (conventional and
endoscopic), the collected data were stored according to a
protocol that included:
1. Identification (name, age, gender, race);
2. Date of diagnosis;
3. Patient’s complaints;
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4. Clinical presentation of the disease: Undetermined (I),
Tuberculoid (TT), Borderline tuberculoid (BT), Borderline-
borderline (BB), Borderline-lepromatous (BL),
Lepromatous lepromatous (LL) and pure Neural (NP);
5. Presence of reaction types I, II or Neural;
6. Endoscopic ENT examination.
RESULTS
Among the 173 patients we found 53 with LL
presentation (30.6%), 39 with BL presentation (22.5%), 39
with BT presentation (22.5%), 29 with BB presentation
(16.8%), 7 with I presentation (4.1%), 5 with NP (2.9%) and
one with TT (0.6%) (Table 1), showing agreement with
many different authors in terms of higher frequency of
disease in lepromatous forms. We observed in our study
that 70% of the patients presented ENT complaints related
to the nose and many patients did not correlate nasal
symptoms and Leprosy (Table 1). The most frequent
complaints were nasal obstruction found in 94 patients,
representing 54.3%, followed by epistaxis in 70 patients,
amounting to 40.5%, and elimination of crusts, referred by
50 patients, amounting to 28.9% (Table 2); the same
complaints had been listed by many studies.4,11,12,15-21
In addition to the complaints previously reported as
the most frequent, the patients also reported, in decreasing
order: rhinorrhea in 43 patients (23.7%), hyposmia in 13
patients (7.5%), 13 patients reported nasal pain (7.5%), 11
had nasal pruritus (6.4%), 10 had headache (5.7%), five had
sneezing (2.8%), three patients reported nasal dryness
(1.7%), four had cacosmia (2.3%) and one presented anosmia
(0.6%) (Table 2).
DISCUSSION
We agree with Davey (1974)8 concerning the
negligence of the nasal mucosa examination using anterior
rhinoscopy, which is not performed as a routine in many
treatment centers, despite the knowledge that specialists
have that there may be nasal mucosa affections, even in the
absence of visible clinical signals or symptoms, as reported
by Leloir (1886)13. We also considered that the nose is an
important site of entry and elimination of bacilli
(Mycobacterium leprae), a frequent statement in many
studies 1,5,8,9,12,16-1. In addition to mucosa lesions (Table 3)
found in untreated patients, we detected persistence of these
lesions and even evolution with progressive worsening in
patients in treatment and after treatment with
polychemotherapy, contradicting some authors as Chacko
et al. (1979)11 and Davey (1974)8, which confirmed that
bacillary elimination of nasal mucosa occurs faster when
compared to the skin owing to the fact that many specialists
neglected the nasal mucosa examination. We believe that
there are indeed bacilli in the nasal mucosa after treatment,
but we question the viability of these bacilli, justifying the
fact that we had not performed routine bacilloscopy of na-
sal swab, because we agree with Cerruti et al. (1945)12 that
stated that in contacts and in patients with neural
presentation, the result of bacilli in nasal mucus is negative
in most cases, requiring repetition of the exam.
We advocate the process to rule out other diseases
with Hansen’s signs and symptoms, the performance of nasal
biopsy for histopathological exam, even when the
dermatological and neurological investigation is negative.
We would like to point out that it is possible to suspect of a
case of Leprosy only through the clinical history associated
with the ENT examination, especially when we perform it
with rigid or flexible endoscope, a fact also observed by the
authors Soni (1997)21 and Fokkens et al. (1998)22. The exam
enables the identification of mucosa lesions that are not
observed when we use only nasal speculum in the anterior
rhinoscopy, such as hansenomas and vasculitis (Photo 3).
We also observed that 52 patients did not report ENT
complaints, a fact observed also by Cerruti et al. (1945)12 ;
despite the absence of symptoms, these patients presented
nasal lesions, justifying the performance of the ENT exam
and mainly the endoscopic examination of nasal cavity
mucosa in all patients with Leprosy, regardless of the
complaints or clinical presentation of the disease.
As to olfaction affections, Barton et al. (1976)16 showed
that it is a common complaint, found in 44% of the 150
patients seen with the lepromatous presentations, referring
that the affection is related with severity of clinical
presentations in the nasal mucosa. Despite the fact that we
found a smaller number of patients with olfaction affections
relative to previous references, amounting to 7.5% of total
hyposmia in assessed patients (Table 2), this complaint was
seen not only in patients with lepromatous presentation (LL)
- seven cases, but also in patients with BL (two), BB (three)
and BT (one) presentations, and these patients were in a
more advanced stages of the disease or in a reaction episode,
which made us agree with the authors. We would like to
point out the fact that this complaint may be found in any
clinical presentation of the disease.
Table 1. Relation between clinical presentation and presence
or not of nose related complaints.
Patients with  Patients w/out Clinical presentation
complaint complaint
48 5 LL
26 13 BL
22 17 BT
17 12 BB
5 0 NP
3 4 I
0 1 TT
 Total 121 52
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Attempts to magnify the mucosa examination were
tried with the use of surgical microscope 23,24, later replaced
by telescope for nasal examination. We can observe the
identification of lesions using rigid or flexible telescope,
which provides characterization of mucosa lesions as
suspected of Leprosy, which made us exclude other diseases
that were also frequent in our service, such as tuberculosis,
leishmaniasis, paracoccidioidomycosis, syphilis, sarcoidosis,
rhinoscleroma, ozena and even allergic rhinitis or acute viral
rhinitis. We used as a routine the clinical and laboratory
investigation of all suspected patients, in addition to not
performing exams in the presence of colds or allergic crisis
to prevent influence of the results.
Before the introduction of the telescope, some authors
5,16,17 stated that there were no nasal mucosa lesions in
patients with Tuberculoid (TT) or Borderline (BT and BB)
presentations, but we found 40 patients with lesions and TT
and BT presentations and we noticed that regardless of the
clinical presentation, we could found mucosa lesions even
in the absence of complaints and at any disease stage.
We identified nasal mucosa lesions in all assessed
patients (100%) (Table 3), a percentage close to that reported
in the study by Barton et al. (1976)16 which found early
nasal cavity lesions in 95% of the patients with LL and BL
presentations. Among the most frequent lesions, we
identified nasal mucosa infiltration (Photo 1), defined in the
literature 5,16 as granulomatous infiltration of the mucosa and
referred by the patients as nasal obstruction. Even considering
the apparent permeability of the nasal cavity, patients may
refer nasal obstruction, a common complaint of atrophic
leprous rhinitis, associated with reduction of sensitivity,
inspiration and expiration perception, initially unilateral and
later bilateral, without response to use of topical
vasoconstrictor in view of major mucosa infiltration.5,8,16,22
Fokkens et al. (1998)22 found in 18 out of 40 patients
the lepromatous form of infiltration and nasal obstructive
complaint. We observed infiltration in 140 patients,
representing 80.9% of the total, more frequent in the
Table 2. Relation between nasal complaints and clinical presentations.
Complaints NP LL BL BB BT TT I Total %
Nasal obstruction 2 40 21 13 14 1 3 94 54.3
Epistaxis 2 38 15 4 10 0 1 70 40.5
Crusts 1 26 12 2 5 1 3 50 28.9
Rhinorrhea 1 21 8 5 6 0 2 43 23.7
Hyposmia 0 7 2 3 1 0 0 13 7.5
Nasal pain 0 6 2 3 2 0 0 13 7.5
Pruritus 0 2 1 2 6 0 0 11 6.4
Headache 0 6 2 1 1 0 0 10 5.7
Sneezing 0 1 1 1 1 0 1 5 2.8
Cacosmia 0 3 0 1 0 0 0 4 2.3
Dryness 0 1 1 0 1 0 0 3 1.7
Use of vasoconstrictor 0 1 0 0 1 0 0 2 1.2
Anosmia 0 1 0 0 0 0 0 1 0.6
Key: Undetermined (I), Tuberculoid (TT), Borderline tuberculoid (BT), Borderline-borderline (BB), Borderline-lepromatous (BL), Lepromatous
lepromatous (LL) and pure Neural (NP)
Table 3. Relation of endoscopic findings and clinical presentations of the disease:
Endoscopic findings NP LL BL BB BT TT I Total %
Infiltration 4 38 31 26 36 1 4 140 80.9
Rugosity 5 16 20 19 18 1 2 81 46.8
Dryness 2 24 11 16 13 1 0 67 38.7
Vasculitis 5 22 10 11 17 1 1 67 38.7
Crusts 1 32 10 1 8 1 1 54 31.2
Paleness 1 12 9 6 17 1 4 50 28.9
Ectasias 4 19 5 8 9 1 1 47 27.2
Hyperemia 2 14 12 1 10 1 1 41 23.7
Ulceration 0 23 6 1 4 0 0 34 19.7
Blood 3 5 5 10 3 0 0 26 15
Atrophy 3 9 4 3 4 0 0 23 13.3
Moisture 0 1 4 3 6 0 1 15 8.7
Secretion 0 4 4 2 3 0 0 13 7.5
Perforation 1 6 1 0 1 0 0 9 5.2
Hansenomas 0 7 1 1 0 0 0 9 5.2
Synechia 0 1 0 0 0 0 0 1 0.6
Legendas: Undetermined (I), Tuberculoid (TT), Borderline tuberculoid (BT), Borderline-borderline (BB), Borderline-lepromatous (BL), Lepromatous
lepromatous (LL) and pure Neural (NP)
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lepromatous forms (38 patients), as also referred by many
other authors. However, our sample is greater, owing to the
fact that we could observe mucosa lesions in all clinical
presentations of the disease. We found only three patients
that used topical vasoconstrictors because of respiratory
difficulties. The limited use is probably related with early
diagnosis and treatment of these patients by the Service of
Otorhinolaryngology, IPEC/ Fiocruz, or the low purchasing
power of the population and medication high prices. We
think that in patients with damaged mucosa, the use of
topical vasoconstrictor could lead to marked worsening of
nasal mucosa, meaning that its use is contraindicated as
treatment, which could cause superficial ulceration, epistaxis
and eventually septal perforation.
In general, lesions are located on the anterior-inferior
portions of the nasal cavities, regions appointed by all authors
because it provides predisposing factors such as easy access
of bacilli, mechanical trauma, low temperature, and others.
As to epistaxis, we could notice that most cases were
related to mechanical trauma and the act of blowing the
nose intensively, such as the attempt to remove the crusts
4,12,15,16 or influenced by external factors, such as the topical
drugs reported before, inhalation drugs, arterial blood
hypertension and hormonal abnormalities, which provide
greater capillary fragility, in addition to marked vasculitis,
observed especially in the anterior septal region (Kiesselbach
area), predisposing to nasal bleeding 21 (Photo 2).
In addition to infiltration and presence of blood on
the mucosa of nasal cavities, we could identify the presence
of crusts (Photos 1, 2 and 4) at the nasal endoscopy of 54
patients, representing 31.2% of the 173; it was also a frequent
finding in the study by Barton (1974)5, who found it in 74%
of the 77 studied patients, by Fokkens et al. (1998)22, who
found 62% among the 40 studied patients, and by Srinivasan
Photo 1. LL presentation with septal anterior-inferior damage,
presence of vasculitis, dryness, infiltration, mucosa hyperemia, crusts
and blood spots.
Photo 2. BT presentation with bleeding areas on the septal anterior-
inferior region, crusts, and infiltration.
Photo 3. LL presentation with dryness, vasculitis and hansenomas. Photo 4. Pure Neural presentation with dryness, hyperemia, vasculitis,
crusts and blood.
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et al. (1998)25 in 92% of the 25 patients with Lepromatous
presentation. Our percentage was smaller when compared
to the other studies, but we emphasize that this figure is
higher when we analyze only BL and LL presentation,
amounting to 24.3% of the 42 studied patients that had it.
Crusts may be found in any clinical presentation,
ranging in amount, size, shape, consistency and color and
they are comprised by more or fewer leukocytes (purulent
crusts), more or less number of red cells (hematic crusts),
fibrin, saprophyte germs and epithelial cells at different stages
of degeneration. In crusts that cover the ulcerations, in
addition to the above-mentioned elements, we can evidence
other cell elements, common to infiltrations, followed by
necrobiosis of underlying tissues, that may be strongly
adhered to septal mucosa and other areas. The presence of
crusts is justified by marked dryness of nasal secretion, which
takes place during the infectious process by damage to the
trigeminal nerve (5th nerve) responsible for parasympathetic
innervation, which enables the secretory action of mucosa
glands, given that Mycobacterium leprae has neural tropism.4
Barton (1974)5 had not observed lesions in patients
with Tuberculoid and Neural presentations, stating that the
affection of the latter is restricted only to the peripheral
nerve system, generating neural thickness and atrophies and
sequels. We attracted the attention of specialists because
we found considerable frequency of mucosa lesions in these
two clinical presentations of the disease.
As to nasal mucosa atrophy, it was found in 23 patients,
nine LL, four BL, four BT, three BB and three NP, which may
be present from the onset of the disease or after the remission
of the infiltration process, in which the atrophy is justified
by dryness of mucosa glands and marked vasculitis (Photo
4) found in 67 patients (38.7%).
We could observe that vasculitis leads to reduction of
blood circulation, a fact that made us raise the hypothesis
that its intervention on the action of polychemotherapic
treatment in the nasal mucosa could enable bacillus viability
with progression of nasal lesions; in addition, there is
persistence in the mucosa even after polychemotherapy,
which is observed in patients with reactions types I, II or
Neural years after treatment and comprising, with it, a new
theory for the conduction of future studies in the area.
CONCLUSION
Because the nose is considered the entry and exit
point of Mycobacterium leprae, we would like to attract the
attention of healthcare specialists, specially
Otorhinolaryngologists, to suspect of Leprosy in patients who
have nasal lesions with infiltration, crusts and vasculitis,
because we found mucosa affections in all patients seen in
this study. The identification of mucosa lesions using rigid or
flexible endoscopy provides further accuracy and early
diagnosis, and the Otorhinolaryngologist is indispensable to
work with the multidisciplinary team for follow-up and
treatment of patients, preventing the sequelae that
contribute to disease stigma and social exclusion.
REFERENCES
1. Azulay e Azulay, Dermatologia. Editora Guanabara Koogan. 2 ª
Edição; 1999.
2. Guia de Vigilância Epidemiológica 2001. Capítulo 5.13. Hanseníase.
3. Disponível em http://www.funasa.gov.br/pub/GVE/GVE0513B.htm.
Acessado em 22 de setembro de 2001.
4. Lombardi, Ferreira Motta e Oliveira, Hanseníase, epidemiologia
e controle – São Paulo: Imprensa Oficial do Estado: Arquivo do
Estado; 1990.
5. Chacko CJ, Bhanu T, Victor V, Alexander R, Taylor PM, Job CK.
The significance of changes in the nasal mucosa in indeterminate,
tuberculoid and borderline leprosy. Lepr India 1979; 51(1): 8-22.
6. Barton RPE. A clinical study of the nose lepromatous leprosy,
Lepr Rev 1974; 45: 135-44.
7. Guia de controle da Hanseníase. Ministério Da Saúde (BR). Fun-
dação Nacional de Saúde. Brasília (DF); 1994.
8. Oliveira MLW. Controle da hanseníase – uma proposta de integração
ensino-serviço. Ministério da Saúde: 1-120, 1989.
9. Davey TF. The Nose In Leprosy: Steps for a better understanding.
Lepr Rev 1974; 45 (2): 97-103.
10. Green CA, Katoch VM, Desikan KV. Quantitative estimation of
Mycobacterium leprae in exhaled nasal breath. Lepr Rev 1983;
54: 337-40.
11. Talhari S, Neves GR. Hanseníase – Dermatologia Tropical. Rio de
Janeiro. 3ª Edição; 1997.
12. Cristofolini L. Pacientes em quimioterapia anti-hansênica: proble-
mas nasais. São Paulo: USP, 1991. 111p. Tese. (Doutorado em
Enfermagem)
13. Cerruti H, Bechelli LM, Berti A, Souza Lima M. Contribuição ao
estudo da lepra nasal. Rio de janeiro: Imprensa nacional; 1945.
14. Léloir. Lésions des muqueuses. Traité pratique et theorique de la
leper; 1886. 71-87.
15. Barton RP, Rees RJ, Mc Dougall AC, Ellard GA. The nose in
lepromatosus leprosy; bacteriological and histopatological studies
of patients treated with dapsone monotherapy for varying periods
of time. Int J Lepr Other Mycobact Dis 1982; 50 (1): 58-67.
16. Barton RPE. The Management of Leprous Rhinitis. Lepr Rev 1973;
44: 186-91.
17. Barton RPE, Davey TF. Early leprosy of the nose and throat. J
Laryngol Otol 1976; 90 (10): 953-61.
18. Job CK, Karat AB, Karat S. The histopathological appearance of
lepros rhinits and pathogenesis of septal perforation in leprosy. J
Laryngol Otol 1966; 80 (7): 718-32.
19. The Nasal Excretion Of Leprosy Bacilli. Lepr Rev 1978; 4 (49):
265-7.
20. Valverde B. Manifestação inicial da Lepra. Brasil Médico: 53; 1923.
21. Soni NK. Epistaxis and leprosy. Indian J Lepr 1988; 60 (4): 562-
5.
22. Soni NK. Microscopic rhinoscopy in lepromatous leprosy. J Laryngol
Otol 1997; 111: 122-4.
23. Fokkens WJ, Trenite GJN, Virmond M, Kleinjan A, Andrade VLG,
Van Baar NG, Naafs B. The Nose in Leprosy: Immunohistology of
the nasal mucosa. Int J Lepr Other Mycobact Dis 1998; 66: (3).
24. Belal A. Surgical microscopy of the nose. New frontiers in nasal
diagnosis and treatment J Laryngol Otol 1978; 92 :197-207.
25. Prades J. Endonasal microscopy. Acta ORL Iber-Amer 1970; 21:
184-6.
26. Srinivasan S, Nehru VI, Mann SBS, Sharma VK, Bapuraj JR, Das A.
Study of ethmoid sinus involvement in multibacillary leprosy.
The Journal of Laryngology and Otology 1998; 112: 1038-41.
